AGP Executive Report
Last update: 12 hours agoBiotech Deal in Germany: AGC Biologics (Heidelberg) has been picked by Teikoku Seiyaku to develop and manufacture its rhMMP-7 therapy (KTP-001) for lumbar disc herniation—starting with cell bank work in Germany before process development and GMP production move to Japan. EU Antitrust Pressure: The European Commission is reportedly preparing a record, triple-digit million-euro fine for Google under the Digital Markets Act, with Google pushing back that the DMA changes hurt user experience. Energy & Markets Mood: Stocks jumped and oil eased on hopes for progress in US-Iran talks over the Strait of Hormuz, while investors watch timing and tone. Consumer Tech in Germany: Vodafone rolls out a 5G upgrade aimed at faster uploads (up to ~200 Mbps) for social media and cloud use. Health & Policy: Tilray is in London for Cannabis Europa, pitching evidence-led regulation. War’s Human Cost: Kyiv media offices were damaged in a May 24 Russian strike, with journalists among the casualties.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
